Laura Ferguson
MD, MS, MSTR
Clinical Instructor & Attending Physician, Penn Pulmonary & Critical Care
Laura is a pulmonologist with a background in bioengineering. In the lab she works on developing nanomedicine to treat interstitial lung disease, ex vivo human lung studies of nanocarriers, and next-generation RBC-hitchhiking of nanocarriers.
Kate Rubey
MD
Postdoc & Attending Physician, CHOP Neonatology
Kate is a neonatologist at CHOP, working in the neonatal ICU (NICU), taking care of critically ill infants. In lab she works on nanomedicine for severe infections, especially pneumonia, and the mechanisms by which neutrophils recognize nanoparticles.
Sahiley Reyes-Esteves
MD, PhD
Resident, Penn Neurology
Sahily is primarily doing clinical work, but is also working on developing targeted nanocarriers for treating acute ischemic stroke.
Chief Operating Officer (COO)
Jichuan Wu
MD, PhD
Jichuan trained in China as a neonatologist (critical care for infants), then worked at Temple University for 15+ years on animal models of acute critical illnesses (ACIs), focused mostly on ARDS and traumatic brain injury. He joined the Brenner Bioengineering Lab in the summer of 2019, and directs animal experiments on ACIs.
Jia Nong
PhD
Postdoc
Jia is working on the development of targeted nanomedicine for the treatment of acute illness, and to understand the interaction of nanocarriers with white blood cells to facilitate the engineering and applications of the nanomedicine.
Zhicheng Wang
PhD
Postdoc
Zhicheng works on the biophysics of how nanoparticles interact with the blood, and how we can use these principles to engineer better nano-scale therapeutics.
Eno-Obong Essien
MD
Postdoc and Fellow, Penn Pulmonary Division
Eno is working to develop nanocarriers to deliver small molecule drugs and RNA in ARDS models.
Marco Zamora
PhD Student, Drexel Bioengineering
Marco is working on two projects. The first is the development of a nanomedicine-based therapeutic for ARDS using RNA delivery. The second project involves how the innate immune system interacts with nanocarriers.
Mike Zaleski
PhD Student, Penn Pharmacology
Mike leads a project in collaboration with a pharmaceutical company to create a nanomedicine-based therapeutic for ARDS (acute respiratory distress syndrome).
Anush Lingamoorthy
Ph.D. Student, Drexel Electrical Engineering
Anush is the lead engineer in developing a self-driven wearable medical drug delivery device. The purpose of the device is to combat substance use disorders.
Serena Omo-Lamai
PhD Student, Penn Bioengineering
Serena is developing nano-scale drug carriers to deliver small molecule drugs and RNA to the brain, for stroke, traumatic brain injury, and hopefully more.
Liam Chase
Research Specialist
MSE Student, Penn Bioengineering
Liam's background is in Bioengineering and Chemistry. He is developing new methods to detect infusion reactions and nanomedicine-based therapeutics for various diseases.
Tiny Human
Nanoscientist
Yufei Wang
PhD
Postdoc
Yufei is working on the interaction of nanoparticles with in vivo proteins, and their potential application on precise nanodrug delivery.
Carolann Espy
PhD Student, Penn Pharmacology
Carolann is pursuing her Ph.D. in Pharmacology. Her current project is focused on preventing nanocarriers from activating the innate immune system.
Manthan Patel
Manny works on delivering small molecule drugs and nucleic acids using LNPs, focusing on reducing carrier and cargo toxicities.
PhD Student, Penn Pharmacology
Aparajeeta Majumder
Research Specialist
Aparajeeta's work is focused on delivering lipid nanoparticles to the brain, specifically targeting intracerebral hemorrhage.